Cellcom Israel, Ltd.
CEL
CEL was delisted on the 8th of February, 2021.
3 hedge funds and large institutions have $6.76M invested in Cellcom Israel, Ltd. in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 9 closing their positions.
75% less capital invested
Capital invested by funds: $26.5M → $6.76M (-$19.8M)
75% less funds holding
Funds holding: 12 → 3 (-9)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$966K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
-$21.4M |
| 2 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$80K |
| 3 |
Barclays
London,
United Kingdom
|
-$39K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$38K |
| 5 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
-$9K |
CEL Hedge Fund Activity: Q2 2021 in Review
3 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cellcom Israel, Ltd. (CEL) for Q2 2021, worth a combined $6.76M — down 75% from $26.5M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of CEL and 0 opened new positions — a net loss of 9 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was ARK Investment Management, adding an estimated $966K. The largest seller was Clal Insurance, exiting entirely with an estimated $21.4M sold.
- 3 institutional investors held Cellcom Israel, Ltd. (CEL) as of Q2 2021, down from 12 in Q1 2021.
- Funds reported $6.76M of Cellcom Israel, Ltd. stock for Q2 2021, down 75% quarter-over-quarter.
- 0 funds opened new Cellcom Israel, Ltd. positions in Q2 2021 and 9 closed out, a net change of -9 holders.
- The largest Cellcom Israel, Ltd. buyer in Q2 2021 was ARK Investment Management, an estimated $966K added.
- The largest Cellcom Israel, Ltd. seller in Q2 2021 was Clal Insurance, an estimated $21.4M sold.
Based on aggregated 13F filings for Q2 2021.